CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Public ClinicalTrials.gov record NCT00643617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer and to evaluate the effects of this treatment on the quality of life over time.
Study identification
- NCT ID
- NCT00643617
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 307 participants
Conditions and interventions
Conditions
Interventions
- CyberKnife Stereotactic Radiosurgery - Low Risk Radiation
- CyberKnife Stereotactic Radiosurgery - Intermediate Risk Radiation
Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 22, 2007 (Actual)
- Primary completion
- Apr 7, 2022 (Actual)
- Completion
- Apr 7, 2022 (Actual)
- Last update posted
- May 9, 2023
2007 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mitchell Cancer Center University of South Alabama | Mobile | Alabama | 36604 | — |
| Community Regional Medical Center | Fresno | California | 93721 | — |
| Long Beach Memorial Medical Center | Long Beach | California | 90806 | — |
| Pasadena Cyberknife Center | Pasadena | California | 91105 | — |
| CyberKnife Centers of San Diego | San Diego | California | 92101 | — |
| Penrose Cancer Center | Colorado Springs | Colorado | 80907 | — |
| Colorado Cyberknife | Lafayette | Colorado | 80026 | — |
| New Millenium CyberKnife | Brandon | Florida | 33511 | — |
| JFK Comprehensive Cancer Center | Lake Worth | Florida | 33461 | — |
| South Florida Radiation Oncology | Wellington | Florida | 33449 | — |
| Elmhurst Memorial Hospital | Elmhurst | Illinois | 60126 | — |
| Benefis Health System - Sletten Cancer Institute | Great Falls | Montana | 59405 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89128 | — |
| AtlantiCare Regional Medical Center | Egg Harbor | New Jersey | 08234 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| St. Anthony Hospital | Oklahoma City | Oklahoma | 73102 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| East Texas Medical Center | Tyler | Texas | 75701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00643617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00643617 live on ClinicalTrials.gov.